Filing Details
- Accession Number:
- 0001209191-21-045846
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-07 17:08:00
- Reporting Period:
- 2021-07-06
- Accepted Time:
- 2021-07-07 17:08:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1610950 | Syneos Health Inc. | SYNH | Services-Commercial Physical & Biological Research (8731) | 273403111 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1660670 | M. Jason Meggs | C/O Syneos Health, Inc. 1030 Sync Street Morrisville NC 27560 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-07-06 | 40 | $43.16 | 60,741 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2021-07-06 | 40 | $90.00 | 60,701 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2021-07-06 | 620 | $46.00 | 61,321 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2021-07-06 | 620 | $90.00 | 60,701 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (Right to Buy Class A Common Stock) | Disposition | 2021-07-06 | 620 | $0.00 | 620 | $46.00 |
Class A Common Stock | Stock Option (Right to Buy Class A Common Stock) | Disposition | 2021-07-06 | 40 | $0.00 | 40 | $43.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-11-01 | No | 4 | M | Direct | |
0 | 2025-07-29 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
- The shares subject to this option vested in four approximately equal annual installments on November 1, 2017; November 1, 2018; November 1, 2019; and November 1, 2020.
- The shares subject to this option vested in four approximately equal annual installments on July 29, 2016; July 29, 2017; July 29, 2018; and July 29, 2019.